[Clinical and fundamental study of guanabenz in hypertensive patients with renal failure].

Author: HayashiS, NishioS, YoshiharaH

Paper Details 
Original Abstract of the Article :
Clinical and fundamental study of Guanabenz were performed in 20 hypertensive patients with renal failure, who were treated by maintenance hemodialysis treatment. The patients received 2 mg of Guanabenz orally, twice a day for 3 months or more. The clinical efficacy of good control was attained in 6...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/3223454

データ提供:米国国立医学図書館(NLM)

Guanabenz: A Potential Treatment for Hypertension in Renal Failure

Hypertension is a common complication in patients with renal failure, posing significant challenges for management. This research investigates the efficacy and safety of guanabenz, an antihypertensive medication, in patients undergoing hemodialysis. The study found that guanabenz was effective in controlling blood pressure in a majority of patients, demonstrating its potential as a treatment option for hypertension in this challenging population. This research offers valuable insights into the therapeutic potential of guanabenz for managing hypertension in patients with renal failure.

A Potential Solution for a Challenging Condition

This research highlights the potential of guanabenz as a viable treatment option for hypertension in patients with renal failure. The study's findings provide a beacon of hope for individuals struggling with this complex condition, offering a potential path to improved blood pressure control and better overall health.

Navigating the Complexities of Renal Failure

This research underscores the importance of individualized care and targeted therapies for managing hypertension in patients with renal failure. The study emphasizes the need for careful monitoring and tailored treatment approaches to ensure optimal outcomes for this patient population. As we continue to explore the vast landscape of renal disease management, this research provides valuable insights into potential treatment options for hypertension in this challenging setting.

Dr. Camel's Conclusion

This research offers valuable insights into the potential of guanabenz for managing hypertension in patients with renal failure. The study provides a glimpse into the possibility of improving blood pressure control and overall health outcomes for this patient population. As we navigate the complexities of renal disease management, research like this offers a path toward more effective treatment strategies and better care for individuals with this challenging condition.

Date :
  1. Date Completed 1989-03-21
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

3223454

DOI: Digital Object Identifier

3223454

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.